ORISE GEL
Received Jan 20, 2023 · Event occurred Dec 1, 2022
Report 3005099803-2023-00146 · MDR key 16215218
Device
Generic name
Submucosal Injection Agent
Manufacturer
Boston Scientific CorporationProduct problems
- Adverse Event Without Identified Device or Use Problem
- Adverse Event Without Identified Device or Use Problem
Patient
Unknown
- Granuloma
- Granuloma
Narrative
Description of Event or Problem
BOSTON SCIENTIFIC CORPORATION BECAME AWARE THAT ORISE GEL WAS USED AS A LIFTING AGENT ON AN UNKNOWN DATE VIA A SOCIAL MEDIA TWITTER POST. ACCORDING TO THE LIMITED INFORMATION AVAILABLE FROM THE POST, ORISE GEL PENETRATED INTO THE SEROSA. A RESECTION WAS PERFORMED; HOWEVER, IT IS UNKNOWN IF THE RESECTION WAS PERFORMED DUE TO ORISE GEL. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION REGARDING THE CIRCUMSTANCES SURROUNDING THIS EVENT HAVE BEEN UNSUCCESSFUL TO DATE. SHOULD ADDITIONAL RELEVANT DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
Additional Manufacturer Narrative
DATE OF EVENT: THE EXACT DATE OF THE EVENT IS UNKNOWN. THE PROVIDED EVENT DATE WAS CHOSEN AS A BEST ESTIMATE BASED ON THE DATE THAT THE MANUFACTURER BECAME AWARE OF THE EVENT. THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE UPN AND LOT NUMBER; THEREFORE, THE LOT EXPIRATION AND DEVICE MANUFACTURE DATES ARE UNKNOWN. (B)(4).
Remedial action
- Recall